Results 51 to 60 of about 84,913 (300)

Baseline characteristics and enrichment results from the SONAR trial [PDF]

open access: yes, 2018
Aim: The SONAR trial uses an enrichment design based on the individual response to the selective endothelin receptor antagonist atrasentan on efficacy (the degree of the individual response in the urinary albumin‐to‐creatinine ratio [UACR]) and safety/
Andress, Dennis L.   +15 more
core   +3 more sources

Novel pathways of heart failure with preserved ejection fraction [PDF]

open access: yes, 2016
INTRODUCTION: Diastolic heart failure (HF) i.e., HF with preserved ejection fraction (HFpEF) accounts for ~50% of all clinical HF presentations; but unlike systolic HF i.e., HF with reduced ejection fraction (HFrEF), there are no evidenced based ...
Li, Shanpeng
core   +2 more sources

Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression [PDF]

open access: yesJournal of Biological Chemistry, 2001
Growing evidence suggests an involvement of the endothelin B receptor (ET(B)-R) in blood pressure-dependent arterial remodeling. To study the molecular mechanisms leading to deformation-induced ET(B)-R expression, we have cultured rat aortic smooth muscle cells on flexible elastomers and, when grown to 70% confluence, periodically stretched them for 6 ...
Cattaruzza, Marco   +2 more
openaire   +3 more sources

Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes. [PDF]

open access: yesPLoS ONE, 2018
To characterize the relationship between endothelin-1 and fibrosis in epiretinal membranes in proliferative diabetic retinopathy and explore the role of endothelial-mesenchymal transition in these membranes.Membranes were obtained from eyes undergoing ...
William Chang   +2 more
doaj   +1 more source

Chronic Activation of Endothelin B Receptors [PDF]

open access: yesHypertension, 2007
Endothelin (ET) exerts powerful pressor actions primarily through activation of the ET A receptor subtype. The ET B receptor (ET B R) subtype, on the other hand, is generally thought to initiate physiological actions that decrease arterial pressure.
Gregory, Fink   +4 more
openaire   +2 more sources

Contribution of Piezo2 to endothelium-dependent pain. [PDF]

open access: yes, 2015
BackgroundWe evaluated the role of a mechanically-gated ion channel, Piezo2, in mechanical stimulation-induced enhancement of hyperalgesia produced by the pronociceptive vasoactive mediator endothelin-1, an innocuous mechanical stimulus-induced ...
Bogen, Oliver   +3 more
core   +2 more sources

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Effects of magnesium treatment in a model of internal capsule lesion in spontaneously hypertensive rats [PDF]

open access: yes, 2008
<p><b>Background and Purpose:</b> The study aim was to assess the effects of magnesium sulfate (MgSO4) administration on white matter damage in vivo in spontaneously hypertensive rats.</p> <p><b>Methods:</b> ...
Gallagher, L.   +8 more
core   +1 more source

HSP70 governs permeability and mechanotransduction in primary human endothelial cells

open access: yesFEBS Open Bio, EarlyView.
HSP70 chemical inhibition reduces endothelial cell proliferation and increases permeability, the latter supported by normal interendothelial junctional protein distribution. HSP70 also plays a role in shear stress response, a hemodynamic force naturally present in blood vessels and correlated with vessel protection.
Andrea Pinto‐Martinez   +5 more
wiley   +1 more source

Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease

open access: yesBMC Cardiovascular Disorders, 2009
Background Endothelin-1 and angiotensin II are strong vasoconstrictors. Patients with ischemic heart disease have elevated plasma levels of endothelin-1 and angiotensin II and show increased vascular tone.
Malmsjö Malin   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy